Biotech

All Articles

Bicara, Zenas seek IPOs to press late-phase assets towards market

.Bicara Therapies as well as Zenas Biopharma have actually supplied clean catalyst to the IPO market...

Genentech to finalize cancer immunology research team

.Genentech is going to close its own cancer immunology investigation department, and also unit head ...

Kezar goes down strong lump yet to verify its worth in stage 1 test

.Kezar Lifestyle Sciences is actually falling its own unpromising period 1 strong tumor medicine as ...

Acelyrin goes down izokibep, drops 3rd of team

.Regardless of izokibep sustaining its newfound winning touch in the center, Acelyrin is actually no...

Rivus' period 2 obesity-related cardiac arrest test reaches endpoint

.Rivus Pharmaceuticals has actually plumped up the potential customers of its own fat-busting, muscl...

Ovid halts preclinical work, IV program after soticlestat fail

.Ovid Therapeutics actually exposed final month that it was actually trimming its own head count as ...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Seaport

.Eli Lilly has opened up a $700 million R&ampD center in the Boston Seaport, improving its own RNA a...

Boundless Bio produces 'modest' discharges five months after $100M IPO

.Just five months after securing a $100 million IPO, Limitless Bio is currently laying off some staf...

Halda's $126M will definitely progress 'hold as well as get rid of' lump drugs

.The first stages of oncology R&ampD aren't except interesting brand new modalities, as well as Hald...

Lykos 'disappointments' certainly not revealing study violations with author

.Psychopharmacology has drawn three write-ups about midstage medical trial data determining Lykos Th...